Polaris Innovation Fund
Boston, Massachusettspolarispartners.com
Overview
The Polaris Innovation Fund is a fund managed by Polaris Partners that aims to accelerate the commercial and therapeutic potential of early-stage academic research. It focuses on company creation and growth through an active investment model, backing companies with the potential to create innovative solutions. The team is composed of leaders in scientific research, biopharma, and venture capital.
Portfolio Companies
5
Website
polarispartners.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Candid Therapeutics | Sep 2024 | Series A | Co-investor |
| Delphia | May 2024 | Series A | Lead |
| Larkspur Biosciences | May 2023 | Series A | Lead |
| Satellite Bio | Apr 2022 | Series A | Co-investor |
| Muna Therapeutics | Jul 2021 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.